An experimental comparison and user evaluation of three different dried plasma products
Vox Sanguinis · 2025
DOI: 10.1111/vox.13798 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Vox Sanguinis, 2025. Verfasst von Kristina Ehn und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Blood Component Transfusion, Blood Coagulation Factors, Plasma, Freeze Drying. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Försvarsmakten, ALF Region Stockholm.
Abstract (Originalsprache)
Background and Objectives Access to blood components in pre‐hospital bleeding resuscitation is challenging. Dried plasma is a logistically superior alternative, and new products are emerging. Therefore, we aimed to evaluate laboratory and practical differences in three differently produced dried plasma products. Materials and Methods Single‐donor lyophilized LyoPlas®, pooled‐donor, lyophilized and pathogen‐reduced OctaplasLG Powder®, and single‐donor sprayed‐dried FrontlineODP™ along with fresh plasma (in‐house, pre‐FrontlineODP and OctaplasLG) as controls were analysed ( n = 8). Laboratory tests included measurements of various coagulation factors and thromboelastography. The practical evaluation of the dried plasma products included preparation time, time to dissolve the dried plasma and total time, together with subjective opinions from eight clinical users.
Results
The coagulation factor content was within human reference ranges for all dried plasma, with approximately 10%–20% loss compared with fresh plasma. More variations were observed in the single‐donor products compared with the pooled products. Clot formation analysed by thromboelastography showed normal graphs. Reconstitution time was similar, ranging from on average 7–9 min. In the user evaluation, the reconstitution time and the possibility of using a plastic bag for the transfusion were emphasized as important, the latter fulfilled by two of the products.
Conclusion
The study supports that dried plasma may be produced with lyophilization or spray‐drying technique, as well as with the addition of pathogen reduction, with preserved coagulation capability. The products were reconstituted in acceptable time and deemed feasible for pre‐hospital use by eighth test users.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
- Department of Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden.
- Department of Anaesthesiology and Intensive Care, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Anaesthesiology, Södra Älvsborgs Sjukhus, Borås, Sweden.
- Helicopter Emergency Medical Service, Västra Götalandsregionen, Gothenburg, Sweden.
- Institute of Clinical Sciences, Department of Pediatric Anesthesia and Intensive Care, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
ORCID-Profile: Kristina Ehn
Förderung
- Försvarsmakten
- ALF Region Stockholm
Zitieren
APA
Ehn, K., Skallsjö, G., Romlin, B., Sandström, G., Sandgren, P., & Wikman, A. (2025). An experimental comparison and user evaluation of three different dried plasma products. Vox Sanguinis. https://doi.org/10.1111/vox.13798
Vancouver
Ehn K, Skallsjö G, Romlin B, Sandström G, Sandgren P, Wikman A. An experimental comparison and user evaluation of three different dried plasma products. Vox Sanguinis. 2025. doi:10.1111/vox.13798
BibTeX
@article{Ehn2025,
author = {Ehn, Kristina and Skallsjö, Gabriel and Romlin, Birgitta and Sandström, Göran and Sandgren, Per and Wikman, Agneta},
title = {An experimental comparison and user evaluation of three different dried plasma products},
journal = {Vox Sanguinis},
year = {2025},
doi = {10.1111/vox.13798}
}
EUVIMED